Back
Calidi Biotherapeutics 10K Form
Buy
52
CLDI
Calidi Biotherapeutics
Last Price:
2.16
Seasonality Move:
-22.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLDI News And Ratings
See the #1 stock for the next 7 days that we like better than CLDI
CLDI Financial Statistics
Sales & Book Value
| Annual Sales: | $45K |
|---|---|
| Cash Flow: | $-4.95M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.10 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -18.96660 |
|---|---|
| Net Income (TTM): | $-26.28M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Calidi Biotherapeutics Earnings Forecast
Key Calidi Biotherapeutics Financial Ratios
- The Selling, General & Administrative Expenses for CLDI have been equal to 35,337.78% of Gross Profit Margin.
- The Interest Expense is -3.66% of Operating Income.
- Per Share Earnings over the last 4 years have been positive in 0 years.
Calidi Biotherapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLDI |
| Website: | calidibio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLDI Technical Analysis vs Fundamental Analysis
Buy
52
Calidi Biotherapeutics (CLDI)
is a Buy
Is Calidi Biotherapeutics a Buy or a Sell?
-
Calidi Biotherapeutics stock is rated a Buy
The current Calidi Biotherapeutics [CLDI] share price is $2.14. The Score for CLDI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.